Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.
Listen to this summary
This CSCO-ASCO guideline update asks how best to treat non-metastatic nasopharyngeal carcinoma (stage IB–III) with radiotherapy combined with chemotherapy, given new evidence since 2021. Based on a multidisciplinary review of randomized trials and meta-analyses, the Panel recommends MRI-guided IMRT with image guidance, selective target de-escalation after induction chemotherapy, cisplatin-based concurrent chemoradiotherapy, and gemcitabine-cisplatin or docetaxel-cisplatin-fluorouracil as preferred induction regimens, with metronomic capecitabine as an adjuvant option for higher-risk patients. For PD-1 inhibitors, which improve disease control but lack mature overall survival data, the Panel makes no recommendation for or against routine addition and advises individualized decisions.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of clinical oncology : official journal of the American Society of Clinical Oncology
View all →Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.
Nov 17, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.
Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.
Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.
More in Pediatrics
View all →Nov 20, 2026 · Hormone research in paediatrics
Post-Menarcheal Height Gain After Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty.
Nov 20, 2026 · Hormone research in paediatrics
JUVENILE IDIOPATHIC ARTHRITIS IN CHILDREN WITH TYPE 1 DIABETES: IMPACT OF CURRENT MEDICAL TREATMENT OPTIONS ON ANTHROPOMETRY AND METABOLIC CONTROL.
Nov 20, 2026 · European heart journal
Acute pulmonary embolism: long-term cause-specific mortality in a Chinese nationwide registry.
Nov 20, 2026 · Journal of the American College of Cardiology
Lipid-Lowering Strategies in the Era of Early Atherosclerosis Detection: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.
Nov 20, 2026 · American journal of respiratory and critical care medicine
Glucagon-Like Peptide-1 Agonists or Tezepelumab for Obesity-Associated Asthma: A Cohort Study.
Nov 19, 2026 · Developmental medicine and child neurology
Definition and classification of cerebral palsy operationalized by the Surveillance of Cerebral Palsy in Europe.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


